Skip to content

Chest Wall Muscle Stretching and Acute Effects in Chronic Obstructive Pulmonary Disease

Chest Wall Muscle Stretching and Acute Effects on Volume Variation of Thoracoabdominal Wall and Electromyographic Activity in Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01826669
Enrollment
28
Registered
2013-04-08
Start date
2011-05-31
Completion date
2011-12-31
Last updated
2013-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The study hypothesis is chest wall muscle stretching increase distribution of volume variation of thoracoabdominal wall and reduce electromyographic activity of respiratory muscles in patients with Chronic Obstructive Pulmonary Disease.

Detailed description

Randomized controlled trial involving patients with Chronic Obstructive Pulmonary Disease evaluated before and immediately after a program of stretching muscles of the rib cage or after resting with time similar to the intervention, as volume variation of thoracoabdominal wall by optoelectronic plethysmography and on the electromyographic activity of accessory muscles of respiration.

Interventions

PROCEDUREStretching

Patients submitted to respiratory muscle stretching related to the increase thoracic mobility. Stretching were performed in the upper trapezius, scalenes, sternocleidomastoids, major pectoral and intercostals. The muscle stretching were performed passively by a single therapist trained and experienced. The subjects were positioned supine or lateral, knees flexed in order to correct the lumbar curve. Stretching occurred during the expiratory phase, leading to muscle maximum length, with two series of ten consecutive incursions for each muscle, with an interval of one minute between series. The patients were properly informed to perform slow exhalations and pursed-lip during stretching.

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* clinical and functional diagnosis of Chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2009), * forced expiratory volume in one second (FEV1) less than 80% predicted post-bronchodilator; * clinical stability during the study, * both sexes, * age above 40 years, * body mass index (BMI) between 18.5 and 29.9 kg / m²; * smoking history, * symptoms of cough, * dyspnea or hypersecretion, * ex-smokers for at least three months.

Exclusion criteria

* Disease exacerbation for at least eight weeks, * patients with other respiratory diseases, * cardiovascular or osteoarticular and * participants in pulmonary rehabilitation programs.

Design outcomes

Primary

MeasureTime frame
Distribution of volume variation of thoracoabdominal wall and electromyographic activity of respiratory muscles1 hour

Secondary

MeasureTime frame
Respiratory rate, minute volume, expiratory time, inspiratory time, relation inspiratory time/ total time1 hour

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026